181 related articles for article (PubMed ID: 29499854)
21. Integrative Histologic and Bioinformatics Analysis of BIRC5/Survivin Expression in Oral Squamous Cell Carcinoma.
Troiano G; Guida A; Aquino G; Botti G; Losito NS; Papagerakis S; Pedicillo MC; Ionna F; Longo F; Cantile M; Pennella A; Lo Russo L; Di Gioia G; Mariggiò MA; Lo Muzio L; Pannone G
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30205554
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Significance of Survivin Expression in Patients with Ovarian Carcinoma: A Meta-Analysis.
Gąsowska-Bajger B; Gąsowska-Bodnar A; Knapp P; Bodnar L
J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33669912
[TBL] [Abstract][Full Text] [Related]
23. Transcriptome analysis of CD133-positive stem cells and prognostic value of survivin in colorectal cancer.
Kim ST; Sohn I; DO IG; Jang J; Kim SH; Jung IH; Park JO; Park YS; Talasaz A; Lee J; Kim HC
Cancer Genomics Proteomics; 2014; 11(5):259-66. PubMed ID: 25331798
[TBL] [Abstract][Full Text] [Related]
24. Prognostic Significance of Survivin Expression in Osteosarcoma Patients: A Meta-Analysis.
Liu Y; Teng Z; Wang Y; Gao P; Chen J
Med Sci Monit; 2015 Sep; 21():2877-85. PubMed ID: 26408642
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological and prognostic significance of survivin expression in renal cancer patients: a meta-analysis.
Ma C; Lu B; Sun E
Postgrad Med J; 2017 Apr; 93(1098):186-192. PubMed ID: 27489375
[TBL] [Abstract][Full Text] [Related]
26. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of LncRNA HOTAIR is Associated with Poor Prognosis in Thyroid Carcinoma: A Study Based on TCGA and GEO Data.
Li HM; Yang H; Wen DY; Luo YH; Liang CY; Pan DH; Ma W; Chen G; He Y; Chen JQ
Horm Metab Res; 2017 May; 49(5):388-399. PubMed ID: 28351094
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological significance of PI3K, Akt and survivin expression in gastric cancer.
Gu Y; Jin S; Wang F; Hua Y; Yang L; Shu Y; Zhang Z; Guo R
Biomed Pharmacother; 2014 May; 68(4):471-5. PubMed ID: 24726064
[TBL] [Abstract][Full Text] [Related]
29. A meta-analysis on the role of pleiotrophin (PTN) as a prognostic factor in cancer.
Zhou J; Yang Y; Zhang Y; Liu H; Dou Q
PLoS One; 2018; 13(11):e0207473. PubMed ID: 30427932
[TBL] [Abstract][Full Text] [Related]
30. A bioinformatics analysis of the clinicopathological and prognostic significance of
Zheng HC; Ren DH; Zhang CY; Chen Y; Zhang L
J Obstet Gynaecol; 2023 Dec; 43(1):2216280. PubMed ID: 37227120
[TBL] [Abstract][Full Text] [Related]
31. Survivin (BIRC5) cell cycle computational network in human no-tumor hepatitis/cirrhosis and hepatocellular carcinoma transformation.
Wang L; Huang J; Jiang M; Sun L
J Cell Biochem; 2011 May; 112(5):1286-94. PubMed ID: 21312234
[TBL] [Abstract][Full Text] [Related]
32. Survivin antiapoptotic gene expression as a prognostic factor in non-small cell lung cancer: in situ hybridization study.
Karczmarek-Borowska B; Filip A; Wojcierowski J; Smoleń A; Pilecka I; Jabłonka A
Folia Histochem Cytobiol; 2005; 43(4):237-42. PubMed ID: 16382892
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of survivin in patients with gastric cancer: a systematic review with meta-analysis.
Liu JL; Gao W; Kang QM; Zhang XJ; Yang SG
PLoS One; 2013; 8(8):e71930. PubMed ID: 23936532
[TBL] [Abstract][Full Text] [Related]
34. Prognostic role of survivin in renal cell carcinoma: A system review and meta-analysis.
Xiong C; Liu H; Chen Z; Yu Y; Liang C
Eur J Intern Med; 2016 Sep; 33():102-7. PubMed ID: 27350406
[TBL] [Abstract][Full Text] [Related]
35. [Survivin expression in ovarian germ cell tumors].
Yin RT; Peng ZL; Yang KX; Kang DY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Mar; 38(2):243-5. PubMed ID: 17441339
[TBL] [Abstract][Full Text] [Related]
36. A prognostic 11 genes expression model for ovarian cancer.
Men CD; Liu QN; Ren Q
J Cell Biochem; 2018 Feb; 119(2):1971-1978. PubMed ID: 28817186
[TBL] [Abstract][Full Text] [Related]
37. Prognostic and Clinicopathological Value of Survivin in Diffuse Large B-cell Lymphoma: A Meta-Analysis.
Zhang Y; Wang J; Sui X; Li Y; Lu K; Fang X; Jiang Y; Wang X
Medicine (Baltimore); 2015 Sep; 94(36):e1432. PubMed ID: 26356696
[TBL] [Abstract][Full Text] [Related]
38. [Influence of human epithelial ovarian cancer HO-8910 cells with modified survivin gene on the cell cycle distribution and chemosensitivity].
Peng LP; Huang JM; Zhang GN; Zha X; Ren Y; Fan Y; Deng BF
Zhonghua Fu Chan Ke Za Zhi; 2010 Nov; 45(11):860-4. PubMed ID: 21211287
[TBL] [Abstract][Full Text] [Related]
39. The anticipating value of PLK1 for diagnosis, progress and prognosis and its prospective mechanism in gastric cancer: a comprehensive investigation based on high-throughput data and immunohistochemical validation.
Lin P; Xiong DD; Dang YW; Yang H; He Y; Wen DY; Qin XG; Chen G
Oncotarget; 2017 Nov; 8(54):92497-92521. PubMed ID: 29190933
[TBL] [Abstract][Full Text] [Related]
40. Survivin is not an independent prognostic factor for patients with upper tract urothelial carcinoma: a multi-institutional study.
Mathieu R; Klatte T; Margulis V; Karam JA; Rouprêt M; Seitz C; Karakiewicz PI; Fajkovic H; Wood CG; Weizer AZ; Raman JD; Remzi M; Rioux-Leclercq N; Haitel A; Bensalah K; Lotan Y; Rink M; Kluth LA; Scherr DS; Robinson BD; Shariat SF
Urol Oncol; 2015 Nov; 33(11):495.e15-22. PubMed ID: 26228160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
